Pharma Industry Urges EU to Slow Down Critical Medicines Act Due to Concerns Over Hasty Process
As the European Commission rushes to meet its March 11 deadline for presenting the Critical Medicines Act, the EU’s pharmaceutical industry is raising alarms about the rushed timeline and lack of proper evaluation. Originally promised by Health Commissioner Oliver Várhelyi within the first 100 days of his mandate, the proposal aims to address critical shortages […]
Continue Reading